Analysts Viewpoint
JP Morgan gives an Underweight recommendation for Nektar Therapeutics (NKTR)
In a filing, Nektar Therapeutics revealed its 10% Owner Deep Track Capital, LP unloaded Company’s shares for reported $99630.0 on
Menu
In a filing, Nektar Therapeutics revealed its 10% Owner Deep Track Capital, LP unloaded Company’s shares for reported $99630.0 on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Nektar Therapeutics’s filing revealed that its President & CEO ROBIN HOWARD W unloaded Company’s shares for reported $13622.0 on Feb
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Nektar Therapeutics’s recent filing unveils that its President & CEO ROBIN HOWARD W unloaded Company’s shares for reported $13622.0 on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Nektar Therapeutics revealed its President & CEO ROBIN HOWARD W unloaded Company’s shares for reported $13622.0 on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Nektar Therapeutics’s recent filing unveils that its President & CEO ROBIN HOWARD W unloaded Company’s shares for reported $13622.0 on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or